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PHOTO ESSAYS 
In the shadow of  tomorrow 
Ebola vaccine research in Liberia  
Arsenii Alenichev 
This photo essay draws on images taken by the author in Liberia between August and 
December 2016, as part of an anthropological project exploring the perspectives of 
participants involved in Ebola vaccine research at the peak of the outbreak. In 2014, a US-
Liberian collaboration resulted in the launch of Liberia’s first large-scale randomized Ebola 
vaccine clinical trial. Fifteen hundred people were rapidly recruited to participate in the trial 
and subsequently found to have compliance rates of 98 percent, an achievement that 
researchers had previously thought unimaginable. 
The initial purpose of these photographs was to document some of the spaces and objects 
encountered during fieldwork.1 Later, I came to view these images as evocative of the 
‘ethical variability’ of the trial. I use Petryna’s (2005) concept of ‘ethical variability’ to refer to 
situations in which normative bioethics (routine institutional ethical procedures in clinical 
trial research) fail to account for human subjects’ pragmatic motives to participate in such 
trials. The notion of ethical variability presents a sharp challenge to those who argue that 
 
1 To protect the anonymity of trial participants in the context of significant stigma surrounding Ebola, the 
images presented here contain no people. 
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‘healthy volunteers’ participate in clinical trials out of altruism, providing free labor for 
science and development. 
In this photo essay, I argue that for many Liberians, the decision to participate in Ebola 
vaccine clinical trials was embedded in historical and ongoing systems of exploitation, and 
was powerfully shaped by the fact that trial participation allowed them to obtain medical care 
and socioeconomic benefits that were otherwise out of reach. I suggest that photographs of 
the material and social contexts in which clinical trials unfold in Liberia and elsewhere can 
reveal important dynamics that are not taken into account by normative bioethics. 
 
 
 
 
 
 
 
1. A landscape of precarious employment 
 
Ethical variability is produced by the social, historical, political, and economic contexts in 
which clinical trial research is deployed. Photograph 1 documents a community that might 
be seen, through the lens of normative bioethics, as having made an important, altruistic 
contribution to science and development by hosting Liberia’s first large-scale randomized 
Ebola vaccine clinical trial. Joshua, not pictured in the photograph, was a thirty-five-year-old 
man who lived in this community at the time of my research. He had lived through the 
Liberian civil wars (1989–1997, 1999–2003), and was working as a motorbike taxi driver 
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when Ebola broke out in 2014. At that time, both his low income and his fear that he might 
contract Ebola from his passengers motived him to participate in the vaccine trial. For 
Joshua, participation was a way to protect his health and build economic capital; he hoped to 
receive a job supervising human subjects in upcoming trials at the conclusion of his 
participation. The trial gave participants a small amount of money to cover their travel to 
and from the site; this ‘transport compensation’ became his only source of income when his 
employer fired him because he feared that Joshua might become ill with Ebola from the 
vaccine and infect his passengers (photograph 1 shows a bike that Joshua used to ride but is 
now used by another driver). At the time of the trial, rumors were circulating that the 
vaccine research was causing the spread of Ebola, fueling stigma and discrimination towards 
trial participants and undermining their hopes for a better future through involvement in 
research. In addition to the stigma Joshua bore as a result of his affiliation with what many in 
the community termed ‘Ebola businesses’, he was also stigmatized as a member of ‘zogos’: a 
term that refers to street criminals and thugs in Liberia. In sum, Joshua’s participation in the 
clinical trial, like many others in the community, was not born out of volunteerism and 
altruism, but rather was built upon the precarity of the place where the trial research took 
place. 
 
 
 
 
 
 
 
 
 
 
 
2. ‘Little America’ research unit  
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Why else was it important for precarious Liberians, like Joshua, to become human subjects 
in a large US-Liberian clinical research trial? Photograph 2 depicts a meeting room in the 
first research unit in Liberia to begin running various clinical research projects, which was 
referred to as ‘Little America’ by trial employees and connected to ‘Big America’ through 
regular videoconferences with trial sponsors and regulators. The naming of the research unit 
as a sort of archipelago of the United States has particular social, cultural, and economic 
resonances. Beginning with the establishment of the state in 1822 by American settlers and 
continuing into the present, privileged membership in Liberian society has long been 
equated with access to Western education and medicine, participating in formal employment 
and the cash economy, practicing Christianity, and speaking English (Utas 2003). Until the 
outbreak of the civil wars, wealthy Americo-Liberian families upheld a wardship system of 
exploitation in which people from poor areas traded their labor and compliance with the 
ruling class for a chance to achieve upward mobility in a highly stratified society (Dolo 2011). 
Little America similarly held up the promise of a better future for those who had access to 
this space, while at the same time harboring the risk of exploitation. Little America offered 
trial subjects medical care, workshops led by trial educators, and a variety of other forms of 
social and economic capital. It also implemented a tracking system, whereby people from the 
community were given some formal powers in order to facilitate compliance among trial 
participants. In these ways, Little America emulated the wardship system of the past. Trial 
subjects traded their compliance for various kinds of temporary support and hopes of 
upward mobility (for example, as trackers) in the expanding clinical research sector. Some 
trial subjects had bigger dreams: Joshua and others hoped that trial participation would 
eventually allow them to move to the United States. Photograph 3 reflects this dream: on a 
wall separating Monrovia and the Pacific Ocean, there is a painting of a Liberian driving a 
car somewhere in Brooklyn. 
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3. A wall separating Monrovia and the Pacific Ocean, featuring a painting of the Brooklyn skyline and a 
Liberian car driving alongside it 
 
What actually happened to people when their participation in the trial ended? Participants 
like Joshua received a simple paper certificate to signify their official participation in and 
graduation from the Little America trial. The graduation certificate materialized the quasi-
professional status of trial participants. Participants’ contributions to the trial could be 
characterized as ‘clinical labor’, that is, as one of the many forms of labor that exist globally 
without labor protection (Abadie 2015; Cooper and Waldby 2014; Parry 2015). At the same 
time, graduation from the trial was also an intensely local experience that closely resembled 
the graduation ceremonies that occurred after post-civil war reintegration programs. These 
programs combined labor, training, and temporary financial support with the aim of 
reintegrating ex-combatants and community members alike into post-civil war society 
(Kilroy 2015). Ebola clinical trial research similarly reintegrated marginalized people, like 
Joshua, into the national collective. Tellingly, both post-civil war reintegration programs and 
the Ebola clinical research trial generated expectations that participants would be offered 
ongoing care and support and opportunities for upward mobility, expectations that would be 
disappointed upon graduation.  
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4. A house of a trial graduate 
 
While Joshua hoped that his participation in Ebola clinical trial research would somehow 
provide a route to the kind of life depicted in the mural in photograph 3, instead, after the 
trial was over, he ended up spending a lot of time at home alone (photograph 4), in the 
neighborhood where he continued to encounter the bike that he used to ride and that 
allowed him to earn income. Like the other trial participants I encountered, he was 
disappointed that the care and support he had once accessed through the trial had stopped 
once the active phase of the trial was over. Right up until trial graduation, Joshua held out 
hope that Little America would compensate him for his struggles and the setbacks he had 
experienced as a result of his participation. In particular, he kept hoping that he would soon 
have the opportunity to enroll in other trials as a ‘responsible’ human subject with previous 
trial experience, or that he might become a supervisor or tracker of other human participants 
in upcoming Little America projects. However, none of that happened. Joshua had received 
the experimental vaccine, and only graduates who received the placebo or those who had 
never participated at all were invited to participate in next Ebola vaccine trial. Once Joshua 
received his graduation certificate, he refused to participate in other Little America 
participatory research projects for which he was eligible because he felt used, betrayed, and 
abandoned.  
Joshua’s story is unfinished. Perhaps he decided to commit himself to those other research 
projects for which he was eligible. Perhaps he got his motorbike back, perhaps he is driving 
a car somewhere in Brooklyn. What this photo essay illustrates is the social, historical, and 
economic contexts that shape and constrain ‘voluntary’ decisions to participate in research, 
those which lie beyond the scope of normative bioethical assumptions. By subscribing to 
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one-size-fits-all discourses, normative bioethics risks mispresenting the participatory motives 
of trial subjects seeking recognition and support in settings of precarity. Photography 
combined with ethnography can expose the ethical variability of clinical trials and offer a 
different view on bioethics in practice. 
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